key: cord-1056187-p9yshee4
authors: Haywood, Nathan; Mehaffey, J. Hunter; Kilbourne, Sarah; Mannem, Hannah; Weder, Max; Lau, Christine; Krupnick, Alexander S.; Agarwal, Avinash
title: Impact of broader geographic allograft sharing on outcomes and cost in smaller lung transplant centers
date: 2020-09-06
journal: J Thorac Cardiovasc Surg
DOI: 10.1016/j.jtcvs.2020.09.008
sha: e51c5a47cc9674feb7c973a71515b2f168c49cd2
doc_id: 1056187
cord_uid: p9yshee4

Objective On November 24, 2017, Organ Procurement and Transplantation Network implemented a change to lung allocation replacing donor service area with a 250 nautical mile radius around donor hospitals. We sought to evaluate the experience of a small to medium size center following implementation. Methods Patients (47 pre and 54 post) undergoing lung transplantation were identified from institutional database from January 2016 to October 2019. Detailed chart review and analysis of institutional cost data was performed. Univariate analysis was performed to compare eras. Results Similar short-term mortality and primary graft dysfunction were observed between groups. Decreased local donation (68% vs 6%, p < 0.001), increased travel distance (145 vs 235 miles, p = 0.004), travel cost ($8,626 vs $14,482, p < 0.001), and total procurement cost ($60,852 vs. $69,052, p = 0.001) were observed post implementation. We also document an increase in waitlist mortality post-implementation (6.9 vs 31.6 per 100 patient years, p < 0.001). Conclusions Following implementation of the new allocation policy in a small to medium size center, several changes were in accordance with policy intention. However, concerning shifts emerged including increased waitlist mortality and resource utilization. Continued close monitoring of transplant centers stratified by size and location are paramount to maintaining global availability of lung transplantation to all Americans regardless of geographic residence or socioeconomic status. (Word Count: 219/250)

Large center experience following the lung allocation change has been described, but information regarding smaller centers is lacking. We demonstrate counter-intuitive changes in a small to medium size lung transplant center that may be representative of other similar programs.

Close monitoring and adjustment is essential to maintain availability to all Americans regardless implemented a change to lung allocation replacing donor service area with a 250 nautical mile 3 radius around donor hospitals. We sought to evaluate the experience of a small to medium size 4 center following implementation. Results: Similar short-term mortality and primary graft dysfunction were observed between 9

groups. Decreased local donation (68% vs 6%, p < 0.001), increased travel distance (145 vs 235 10 miles, p = 0.004), travel cost ($8,626 vs $14,482, p < 0.001), and total procurement cost 11 ($60,852 vs. $69,052, p = 0.001) were observed post implementation. We also document an 12 increase in waitlist mortality post-implementation (6.9 vs 31.6 per 100 patient years, p < 0.001). Lung transplantation (LT) has become an accepted and efficacious therapy for treatment 25 of end stage pulmonary failure. 1 Due to the shortage of acceptable donors there exist significant 26 challenges associated with allocation. 2, 3 Historically, the first geographic unit of LT allocation 27 was the donor service area (DSA), which divides the country into 58 regions with defined 28 geographic borders. [3] [4] [5] [6] However, on November 24, 2017, in response to a lawsuit from a 29 transplant candidate in New York, an emergency action change was implemented by the Organ 30 Procurement and Transplantation Network (OPTN) that replaced the DSA with a 250 nautical 31 mile radius around the donor hospital. 5, [7] [8] [9] The OPTN recently published the one-year report 32 detailing national findings since the new allocation policy was implemented. 10 Some of the 33 highlights include higher Lung Allocation Score (LAS) at transplant, longer distance between 34 donor hospital and transplant center, and increased graft ischemia times. 10 

The large center experience in the post policy implementation era has recently been 36 described. 9 While the experience of high volume centers are critically important to understand, 37 small to medium size transplant centers also make up a significant proportion of total LT 38 performed. 11 11 Thus close to half of Americans who receive LT are taken care of in a lower 42 volume program. The experience of such centers, following implementation of the 250 nautical 43 mile system has yet to be described. 44

The University of Virginia (UVA) is a well-established small to medium size LT center 45 located in central Virginia. The program is the primary LT center serving central and 46 J o u r n a l P r e -p r o o f southwestern Virginia, the latter of which is a region shown to be socioeconomically 47 disadvantaged and have lower than average access to large health care facilities. 13 Standard International Society for Heart and Lung Transplantation (ISHLT) grading system was 66 used. 14 

Preoperative characteristics were compared between patients transplanted before and 87 after allocation policy implementation (Table 1) (Table 1) . A larger proportion of male donors were identified in the post 93 implementation era (49% vs 74%, p = 0.01). Donors were similar in terms of age, best PaO2, and 94 CMV positivity. 95

Operative characteristics pre and post implementation were compared (Table 1) . 96

Experiences in both eras were similar in terms of rate of bilateral vs single LT and use of ex vivo 97 lung perfusion (EVLP). While left warm ischemia time decreased between eras (52 vs 45 min, 98 0.03), cold ischemia time and total ischemia times were unchanged. 99

Waitlist characteristics were compared before and after the policy change. Waitlist 101 mortality rate increased from 6.9 to 31.6 per 100 patient years (p<0.001) following 102 implementation. In the pre era there were a total of 59 patients listed compared to 77 in the post 103 era. The daily waitlist size increased between eras [7 (6-9) vs 9 (7-11) patients, p < 0.001]. In the 104 pre era 5 patients were delisted due to either patient condition (1) or patient preference (4). There 105 was 1 waitlist mortality during this time period. The patient expired while inpatient and the cause 106 of death was acute on chronic hypoxic respiratory failure in setting of interstitial lung disease 107 (LAS 76.6). In the post era there were 8 patients delisted due to either patient condition (6) or 108 patient preference (2). There were 5 waitlist mortalities in this era; 3 while listed and 2 shortly 109 after delisting (< 1 week). All mortalities occurred while inpatient and LAS scores were all 110 above 80. Cause of death in 4 patients was acute on chronic respiratory failure in setting of 111 interstitial lung disease. In one case, cause of death was acute respiratory failure in setting of 112 cystic fibrosis with infectious complication. Among all waitlist mortalities, only one patient in 113 the post era was sensitized (PRA 25%). 114

The primary indication for LT was compared pre and post policy change (Table 2) . There 116 was a higher rate of alpha 1 antitrypsin disease prior to implementation (13% vs 2%, p = 0.03) 117 and a non-significant increase in interstitial lung disease after implementation (47% vs 65%, p = 118 0.07). Rate of COPD/emphysema, cystic fibrosis, and pulmonary hypertension were similar 119 between eras. Donor cause of death in the two groups was compared. Similar rates of drug 120 

Postoperative outcomes before and after the allocation policy change were compared 127 (Table 3) . Rate of primary graft dysfunction and short-term mortality (30 and 90-day) were 128 similar between groups. Compared to the post implementation era, there was a significantly 129 higher rate of local donors (68% vs 6%, p<0.001, Table 3 We present an analysis of the post implementation experience of the new lung allocation 140 policy in a small to medium size LT center (Figure 1) . While the rate of local donation decreased 141 and travel distances increased, there was no change in total graft ischemia time, primary graft 142 dysfunction, or short-term mortality. We found an increase in waitlist mortality rate at our 143 institution following the policy change. Additionally, resource utilization, namely travel and 144 procurement cost, significantly increased in the post implementation era. 145

The intention of the 250 nautical mile allocation change was to replace arbitrary 146 geographic constraints of DSAs with a broader, more equitable sharing policy. 8 Granular data is critical to understand experience variation in the post allocation era. In a 160 small to medium size center located in central Virginia, we found that despite increased travel 161 distance, total ischemia times were unchanged following implementation of the new allocation 162 policy. This contradicts previous reports which demonstrate increased ischemia time along with 163 increased travel distance. 9, 10 We feel that this highlights an important distinction at UVA that 164 may be representative of other small to moderate size LT programs. In the pre-policy era, median 165 distance to donor hospital from our facility was 145 miles necessitating air travel for almost all 166 procurements, including the majority of those within our DSA not performed at UVA. For the 167 rare occasion where auto transportation was feasible, travel distances were never less than 30 168 miles. We feel that despite the increase in distance traveled, the travel burden (transportation to 169 and from airport, loading and unloading, etc.) was largely unchanged resulting in similar graft 170 ischemia times. In essence, and perhaps unlike the case for larger centers in densely populated 171 areas, an increase of 50 to 100 miles of flight time did not translate to a difference in ischemic 172 times. Many large LT centers, especially those where procurements often occur in the same city 173 or those that utilize closely located specialized donor care facilities did not have a similar travel 174 experience in the pre-policy era. Such data may explain the previously reported increase in 175 ischemic times post allocation change. As we demonstrate, this may not be reflective of all 176

We found that at our institution there was an increase in recipient LAS between eras. The 178

OPTN 1 year report also showed a significant increase in LAS from 42.4 to 43.6, 10 which is 179 similar to the magnitude of change observed in our study. While statistically significant, the 180 clinical significance of a 1-2 point increase in LAS is questionable. We are hopeful that a 181 durable, meaningful difference will be revealed in time as the number of patients transplanted in 182 the post implementation era grows. While the number of transplants at our center increased in the 183 post allocation era, waitlist size also increased. Therefore, when normalized to median daily 184 J o u r n a l P r e -p r o o f waitlist size, there was actually fewer LTs performed in the post era. We found that organ offers 185 increased following implementation, which is consistent with the increase in waitlist size. Our 186 analysis also demonstrated an increase in waitlist mortality between eras, which contradicts what 187 has been previously reported. 10, 15 This may be due to difference in pathology between eras with 188 generally less alpha 1 antitrypsin and more interstitial lung disease in post compared to pre era. Similar to previous reports we found no difference in short-term mortality or rate of 197 primary graft dysfunction between groups. 9 Reported rates of primary graft dysfunction are 198 within previously published acceptable ranges. 14 The rate of local donation in our study 199 decreased by 90% post implementation, which is a much larger drop than previously reported. 9,10 200 For example, the OPTN 1 year report showed a 56% decrease. 10 Congruent with previous reports, we found that travel cost as well as total procurement 206 cost was significantly higher in the post implementation era. 7, 9, 10 The cost of local organ 207 procurement is made up of travel cost for the procurement team and organ acquisition cost set by 208 the local organ procurement organization (OPO). For non-local procurement where a different 209 OPO covers the donor hospital, there is an additional administrative charge by the home 210 (recipient hospital) OPO for coordinating. 9 Following inflation adjustment we found total 211 procurement cost increased by $8,200 . This increase stems from moderately increased travel 212 expenses-inflation adjusted travel cost increased by $5,856-as well as increased 213 administrative overhead charges from the home OPO for coordinating non-local donation 214 ($9,500). Cost reported represents direct cost and does not include indirect cost, which at 215 academic medical centers can add an additional 40-50% increase. Thus, the true impact is likely 216 even larger in magnitude. Our analysis showed a significant increase in length of stay following 217 implementation of the new allocation system. This change is due to a more conservative 218 discharge approach throughout the late period in response to a high 30-day readmission rate in 219 the early period (25%) and is probably unrelated to the donor geographic change. The late period 220 showed slight improvement with 30-day readmission rate of 22%, and we anticipate further 221 improvements as our approach continues to be optimized. Previous reports have raised concern 222 over the possibility of increased negative fly outs (flying to donor hospital and declining the 223 organ) and the impact this could have on resource utilization following implementation of the 224 new policy. 9 Our analysis showed no difference in the rate of negative fly outs. However, as a 225 non-reimbursed activity, 9 this is a concerning trend that deserves continued close attention as we 226 move further into the post implementation era. strain of this imbalance may force similar small to medium size programs to limit access or even 242 shut down due to financial constraints that may be easily absorbed by larger, high volume 243

centers. This could result in only a handful of large centers in America performing LT, which 244 would be similar to the current Canadian system composed of 4 centers. 16 In this theoretical 245 scenario, American patients in rural areas would need to relocate while waitlisted -posing a 246 significant barrier to care especially in those with limited means. While publically funded 247 healthcare partially supports waitlist relocation in Canada, 17 this would likely be unsustainable in 248 the current American healthcare climate. One potential opportunity to limit costs would be an 249 increase in sharing procurement responsibilities between centers. Doing so would limit travel 250 related cost. Travel restrictions enacted during the Coronavirus Disease 2019 (COVID-19) 251 national pandemic have, to some degree, already forced a shift toward this model. Relying on 252 local centers to aid in procurement will require a level of trust that will take some time to 253

develop. As such, it may be an ideal opportunity to implement remote telemonitoring technology 254

where recipient surgeons could evaluate the organ in real time over video and help make 255 decisions with the local procuring team. Small to medium size transplant centers are important 256 resources that perform almost half of all LTs in the United States. 11 As such, they necessitate 257 close monitoring of post implementation financial stressors. 258

This study has limitations to consider when interpreting the data. Our analysis is limited 259 by its retrospective nature and relatively small sample size. UVA is a small to medium size LT 260 center with practice patterns that may not be reflective of other centers. While number of LT 261 offers where evaluated, we did not assess which organs were initially offered to other centers 262 prior to acceptance. Further study, stratified by region and center size, is needed to characterize 263 number of offers prior to acceptance with the new allocation policy. While referral patterns play 264 an important role in listing, we did not directly evaluate this. Finally, the geographic setting, 265 surrounding population density, and surrounding LT center density at UVA are unique which 266 limit the generalizability of findings. 267

The new lung allocation policy is congruent with the Final Rule's mandate to pursue 268 broader geographic sharing and limit arbitrary geographic borders. 2 

Annual Data Report: Lung

Effect of the lung allocation score on lung transplantation in the United States. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

How Should Lungs Be Allocated for Transplant? Seminars in respiratory and critical care medicine

Lung and heart allocation in the United States

Geographic disparities in lung transplant rates

Organ distribution without geographic boundaries: A possible framework for organ allocation

Monitoring of the Lung Allocation Change, 6-Month Report Removal of DSA as a Unit of Allocation

HRSA Letter to OPTN

Unintended consequences of changes to lung allocation policy

Monitoring of the Lung Allocation Change, 1 Year Report

Center Volume and Extracorporeal Membrane Oxygenation Support at Lung Transplantation in the Lung Allocation Score Era. American journal of respiratory and critical care medicine

The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation. The Journal of thoracic and cardiovascular surgery

Disparities in Lung Cancer Screening Availability: Lessons From Southwest Virginia. The Annals of thoracic surgery

Primary graft dysfunction. Seminars in respiratory and critical care medicine

Effect of broader geographic sharing of donor lungs on lung transplant waitlist outcomes. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Breathe: The Lung Association (Canadian Lung Association). Lung Transplant Information